E de Clercq - JoVE Visualize

Showing results (421-430 of 1,143) with videos related to

Pageof 115

Sort By:

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapyM Baba, D Schols, R Pauwels, et al.

FEBS Letters|June 30, 2006

Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptorL Lenaerts, D Daelemans, N Geukens, et al.

Journal of Virological Methods|November 1, 1991

Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.

Nucleic Acids Symposium Series|January 1, 1985

Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E De Clercq, D Ayusawa, et al.

Virology|October 1, 1988

Inhibition of terminal N- and O-glycosylation specific for herpesvirus-infected cells: mechanism of an inhibitor of sugar nucleotide transport across Golgi membranesS Olofsson, M Milla, C Hirschberg, et al.

Antiviral Research|October 1, 1989

Synthesis and antiviral activity evaluation of 3'-fluoro-3'-deoxyribonucleosides: broad-spectrum antiviral activity of 3'-fluoro-3'-deoxyadenosineA Van Aerschot, P Herdewijn, G Janssen, et al.

Experientia|September 15, 1980

Alopecia in laboratory animals induced by a polyampholyte, polyethylene alanineE De Clercq, J Descamps, P De Somer, et al.

Journal of Medicinal Chemistry|June 1, 1981

Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridineA S Jones, S G Rahim, R T Walker, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981

On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridineH S Allaudeen, J W Kozarich, J R Bertino, et al.

Antiviral Research|June 1, 1985

Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine creamD J Freeman, S L Sacks, E De Clercq, et al.

Pageof 115

Showing results (421-430 of 1,143) with videos related to

Sort By:

Pageof 115

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapyM Baba, D Schols, R Pauwels, et al.

FEBS Letters|June 30, 2006

Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptorL Lenaerts, D Daelemans, N Geukens, et al.

Journal of Virological Methods|November 1, 1991

Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.

Nucleic Acids Symposium Series|January 1, 1985

Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E De Clercq, D Ayusawa, et al.

Virology|October 1, 1988

Inhibition of terminal N- and O-glycosylation specific for herpesvirus-infected cells: mechanism of an inhibitor of sugar nucleotide transport across Golgi membranesS Olofsson, M Milla, C Hirschberg, et al.

Antiviral Research|October 1, 1989

Synthesis and antiviral activity evaluation of 3'-fluoro-3'-deoxyribonucleosides: broad-spectrum antiviral activity of 3'-fluoro-3'-deoxyadenosineA Van Aerschot, P Herdewijn, G Janssen, et al.

Experientia|September 15, 1980

Alopecia in laboratory animals induced by a polyampholyte, polyethylene alanineE De Clercq, J Descamps, P De Somer, et al.

Journal of Medicinal Chemistry|June 1, 1981

Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridineA S Jones, S G Rahim, R T Walker, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981

On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridineH S Allaudeen, J W Kozarich, J R Bertino, et al.

Antiviral Research|June 1, 1985

Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine creamD J Freeman, S L Sacks, E De Clercq, et al.

Pageof 115